Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002311152 | SCV000320282 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-10 | criteria provided, single submitter | clinical testing | The p.T32M variant (also known as c.95C>T), located in coding exon 2 of the PLOD1 gene, results from a C to T substitution at nucleotide position 95. The threonine at codon 32 is replaced by methionine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001770225 | SCV002003800 | uncertain significance | not provided | 2021-04-12 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001854992 | SCV002206136 | uncertain significance | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001854992 | SCV002790200 | uncertain significance | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323482 | SCV004028569 | uncertain significance | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing |